AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan plateau

International Journal of Hematology

Volumn 96, Issue 2, 2012, Pages 200-213

  Buroker, Norman E ^a   Ning, Xue Han ^b   Zhou, Zhao Nian ^c   Li, Kui ^d   Cen, Wei Jun ^d   Wu, Xiu Feng ^c   Zhu, Wei Zhong ^c   Scott, C Ronald ^a   Chen, Shi Han ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c Chinese Academy of Sciences   (China)

^d Lhasa People's Hospital   (China)

Author keywords

Acute and chronic mountain sickness; AKT3; ANGPTL4; eNOS3; Response element; Transcriptional factors; VEGFA

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; HEMOGLOBIN; PROTEIN KINASE B; VASCULOTROPIN A;

ACUTE DISEASE; ADULT; AKT3 GENE; ALTITUDE DISEASE; ANGPTL4 GENE; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE; CHINESE; CHRONIC DISEASE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENOS3 GENE; ERYTHROCYTE COUNT; ETHNIC GROUP; EXON; FEMALE; GENE; GENE CONTROL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DISTANCE; GENETIC VARIABILITY; GENOTYPE; HEART RATE; HEMATOCRIT; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VEGFA GENE;

ALLELES; ALTITUDE; ALTITUDE SICKNESS; ANGIOPOIETINS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; RESPONSE ELEMENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867021164     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1117-7     Document Type: Article

References (60)

1. Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001;345:107-14.
2. Bartsch P, Bailey DM, Berger MM, Knauth M, Baumgartner RW. Acute mountain sickness: controversies and advances. High Alt Med Biol. 2004;5:110-24.
3. Ning XH, Li SP. Health care at high altitude - self-care universal health book. Shanghai: Shanghai Science and Technology Publishing House; 2006. p. 66-8.
4. Monge C. Chronic mountain sickness. Physiol Rev. 1943;23: 166-84.
5. Winslow RM, Monge CC. Hypoxia, polycythemia, and chronic mountain sickness. Baltimore: Johns Hopkins University Press; 1987.
6. Moore LG. Human genetic adaptation to high altitude. High Alt Med Biol. 2001;2:257-79.
7. Wu TY, Li WS, Wei LY, et al. A preliminary studies on the diagnosis of chronic mountain sickness in Tibetan populations. Matsumoto: Press Committee of the 3rd World congress on Mountain Medicine and High Altitude Physiology; 1998.
8. Leon-Velarde F, McCullough RG, McCullough RE, Reeves JT. Proposal for scoring severity in chronic mountain sickness (CMS). Background and conclusions of the CMS Working Group. Adv Exp Med Biol. 2003;543:339-54.
9. Ainslie PN, Ogoh S. Regulation of cerebral blood flow in mammals during chronic hypoxia: a matter of balance. Exp Physiol. 2010;95:251-62.
10. Gassmann M, Soliz J. Erythropoietin modulates the neural control of hypoxic ventilation. Cellular and molecular life sciences. CMLS. 2009;66:3575-82.
11. West JB. The physiologic basis of high-altitude diseases. Ann Intern Med. 2004;141:789-800.
12. Strohl KP. Lessons in hypoxic adaptation from high-altitude populations. Sleep Breath. 2008;12:115-21.
13. Wilson MH, Newman S, Imray CH. The cerebral effects of ascent to high altitudes. Lancet Neurol. 2009;8:175-91.
14. Su B, Xiao C, Deka R, Seielstad MT, Kangwanpong D, Xiao J, Lu D, Underhill P, Cavalli-Sforza L, Chakraborty R, et al. Y chromosome haplotypes reveal prehistorical migrations to the Himalayas. Hum Genet. 2000;107:582-90.
15. Torroni A, Miller JA, Moore LG, Zamudio S, Zhuang J, Droma T, Wallace DC. Mitochondrial DNA analysis in Tibet: implications for the origin of the Tibetan population and its adaptation to high altitude. Am J Phys Anthropol. 1994;93:189-99.
16. Du R, Xiao C, Cavalli-Sforza LL. Genetic distances between Chinese populations calculated on gene frequencies of 38 loci. Sci China C Life Sci. 1997;40:613-21.
17. Maloney J, Wang D, Duncan T, Voelkel N, Ruoss S. Plasma vascular endothelial growth factor in acute mountain sickness. Chest. 2000;118:47-52.
18. Dorward DA, Thompson AA, Baillie JK, MacDougall M, Hirani N. Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir Med. 2007;101:587-94.
19. Walter R, Maggiorini M, Scherrer U, Contesse J, Reinhart WH. Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol. 2001;85:113-7.
20. Stobdan T, Karar J, Pasha MA. High altitude adaptation: genetic perspectives. High Alt Med Biol. 2008;9:140-7.
21. Bigham A, Bauchet M, Pinto D, Mao X, Akey JM, Mei R, Scherer SW, Julian CG, Wilson MJ, Lopez Herraez D, et al. Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data. PLoS Genet 2010; 6:1-14.
22. Yi X, Liang Y, Huerta-Sanchez E, Jin X, Cuo ZX, Pool JE, Xu X, Jiang H, Vinckenbosch N, Korneliussen TS, et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science. 2010;329:75-8.
23. Rupert JL, Koehle MS. Evidence for a genetic basis for altituderelated illness. High Alt Med Biol. 2006;7:150-67.
24. Buroker NE, Ning XH, Zhou ZN, Li K, Cen WJ, Wu XF, Ge M, Fan LP, Zhu WZ, Portman MA, et al. Genetic associations with mountain sickness in Han and Tibetan residents at the Qinghai- Tibetan Plateau. Clin Chim Acta. 2010;411:1466-73.
25. Buroker NE, Ning XH, Zhou ZN, Li K, Cen WJ, Wu XF, Zhu WZ, Scott CR, Chen SH. EPAS1 and EGLN1 associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai- Tibetan Plateau. Blood Cells Mol Dis 2012;49 (in press).
26. Droma Y, Hanaoka M, Ota M, Katsuyama Y, Koizumi T, Fujimoto K, Kobayashi T, Kubo K. Positive association of the endothelial nitric oxide synthase gene polymorphisms with highaltitude pulmonary edema. Circulation. 2002;106:826-30.
27. Hanaoka M, Droma Y, Ota M, Ito M, Katsuyama Y, Kubo K. Polymorphisms of human vascular endothelial growth factor gene in high-altitude pulmonary oedema susceptible subjects. Respirology. 2009;14:46-52.
28. Hackett PH, Oelz O (1992). The diagnoses accord with the Lake Louise scoring system. In: Sutton GC JR, Houston CS, editors. Hypoxia and mountain sickness. New York: Pergamon Press, pp. 327-330.
29. Schneider S, Roessli D, Excoffier L. Arlequin ver. 2. 00: A software for population genetics data analysis. 2.000 Edition. Geneva; 2000.
30. Nei M, Roychoudhury AK. Sampling variances of heterozygosity and genetic distance. Genetics. 1974;76:379-90.
31. Holsinger KE, Weir BS. Genetics in geographically structured populations: defining, estimating and interpreting F(ST). Nat Rev Genet. 2009;10:639-50.
32. Ding K, Zhou K, He F, Shen Y. LDA-a java-based linkage disequilibrium analyzer. Bioinformatics. 2003;19:2147-8.
33. Weir BS. Genetic data analysis: methods for discrete population genetic data. Sunderland: Sinauer Associates; 1990.
34. Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, Sandelin A. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res. 2008;36:D102-6.
35. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004;32:D91-4.
36. Sandelin A, Wasserman WW, Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 2004;32:W249-52.
37. Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci. 2008;121:3487-95.
38. Woolard J, Bevan HS, Harper SJ, Bates DO. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation. 2009;16:572-92.
39. Simonson TS, Yang Y, Huff CD, Yun H, Qin G, Witherspoon DJ, Bai Z, Lorenzo FR, Xing J, Jorde LB, et al. Genetic evidence for high-altitude adaptation in Tibet. Science. 2010;329:72-5.
40. Appenzeller O, Minko T, Pozharov V, Bonfichi M, Malcovati L, Gamboa J, Bernardi L. Gene expression in the Andes; relevance to neurology at sea level. J Neurol Sci. 2003;207:37-41.
41. Patitucci M, Lugrin D, Pages G. Angiogenic/lymphangiogenic factors and adaptation to extreme altitudes during an expedition to Mount Everest. Acta Physiol. 2009;196:259-65.
42. Gao W, Gao Y, Zhang G, Song L, Sun B, Shi J. Hypoxia-induced expression of HIF-1alpha and its target genes in umbilical venous endothelial cells of Tibetans and immigrant Han. Comp Biochem Physiol Toxicol Pharmacol. 2005;141:93-100.
43. Appenzeller O, Minko T, Qualls C, Pozharov V, Gamboa J, Gamboa A, Wang Y. Gene expression, autonomic function and chronic hypoxia: lessons from the Andes. Clinical Auton Res. 2006;16:217-22.
44. Dai J, Rabie AB. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res. 2007;86: 937-50.
45. Harper SJ, Bates DO. VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer. 2008;8:880-7.
46. Xu J, Dou T, Liu C, Fu M, Huang Y, Gu S, Zhou Y, Xie Y. The evolution of alternative splicing exons in vascular endothelial growth factor A. Gene. 2011;487:143-50.
47. Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005;6:209.
48. Ding H, Liu Q, Hua M, Ding M, Du H, Zhang W, Li Z, Zhang J. Polymorphisms of hypoxia-related genes in subjects susceptible to acute mountain sickness. Respiration. 2011;81:236-41.
49. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer. 2005;5: 921-9.
50. Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51.
51. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA. 2001;98:10983-5.
52. Wang P, Koehle MS, Rupert JL. Genotype at the missense G894T polymorphism (Glu298Asp) in the NOS3 gene is associated with susceptibility to acute mountain sickness. High Alt Med Biol. 2009;10:261-7.
53. Sawada T, Kishimoto T, Osaki Y, Okamoto M, Tahara A, Kaetu A, Kurosawa Y, Kotani K. Relation of the Glu298Asp polymorphism of the nitric oxide synthase gene to hypertension and serum cholesterol in Japanese workers. Prev Med. 2008;47: 167-71.
54. Srivastava K, Narang R, Sreenivas V, Das S, Das N. Association of eNOS Glu298Asp gene polymorphism with essential hypertension in Asian Indians. Clin Chim Acta. 2008;387:80-3.
55. Lichtenstein L, Berbee JF, van Dijk SJ, van Dijk KW, Bensadoun A, Kema IP, Voshol PJ, Muller M, Rensen PC, Kersten S. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol. 2007;27:2420-7.
56. Yu X, Burgess SC, Ge H, Wong KK, Nassem RH, Garry DJ, Sherry AD, Malloy CR, Berger JP, Li C. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc Natl Acad Sci USA. 2005;102:1767-72.
57. Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, Favier J, Philippe J, Sibony M, Gasc JM, Corvol P, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol. 2003;162: 1521-8.
58. Smart-Halajko MC, Robciuc MR, Cooper JA, Jauhiainen M, Kumari M, Kivimaki M, Khaw KT, Boekholdt SM, Wareham NJ, Gaunt TR, et al. The relationship between plasma angiopoietinlike protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler Thromb Vasc Biol. 2010;30:2277-82.
59. Wang X, Tomso DJ, Liu X, Bell DA. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol. 2005;207:84-90.
60. Naqvi A, Hoffman TA, DeRicco J, Kumar A, Kim CS, Jung SB, Yamamori T, Kim YR, Mehdi F, Kumar S, et al. A singlenucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression. Hum Mol Genet. 2010;19:4123-33.